IL-2R alpha (CD25) [Basiliximab] Antibody from MYBIOSOURCE INC.
Search, find, compare suppliers for anti-IL-2R alpha (CD25) [Basiliximab] antibody, protein, ELISA kits.
| Edit | |
|---|---|
| Antigenic Specificity | IL-2R alpha (CD25) [Basiliximab] |
| Clone | polyclonal |
| Host Species | Human |
| Reactive Species | human |
| Isotype | n/a |
| Format | Protein A purified |
| Size | 0.2 mg |
| Concentration | n/a |
| Applications | Flow Cytometry (FC/FACS), Block, Immunofluorescence (IF), Immunohistochemistry (IHC), Western Blot (WB) |
| Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
| Description | Recognizes the human IL-2R alpha (CD25). Recombinant monoclonal antibody to IL-2R alpha (CD25). Manufactured using a Recombinant Platform with variable regions (i.e. specificity) from the therapeutic antibody Basiliximab. NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This is a chimeric antibody created for improved compatibility with existing reagents, assays and techniques. |
| Immunogen | n/a |
| Other Names | [Interleukin-2 receptor subunit alpha; IL-2 receptor subunit alpha; IL-2R subunit alpha; IL-2-RA; IL2-RA; TAC antigen; p55; CD25.], [IL2RA; IL2RA; p55; CD25; IL2R; IMD41; TCGFR; IDDM10; IL-2 receptor subunit alpha; IL-2-RA; IL-2R subunit alpha; IL2-RA] |
| Gene, Accession # | [IL-2R alpha], Gene ID: 3559, UniProt: P01589 |
| Catalog # | MBS488159 |
| Price | $425 |
| Order / More Info | IL-2R alpha (CD25) [Basiliximab] Antibody from MYBIOSOURCE INC. |
| Product Specific References | Kovarik et al. Disposition of basiliximab, an interleukin-2 receptor monoclonal antibody, in recipients of mismatched cadaver renal allografts. Transplantation. 1997 Dec 27; 64(12):1701-5. PMID:9422405 |
MYBIOSOURCE INC.
MYBIOSOURCE INC.
P.O. Box 153308
San Diego CA 92195-3308
P: 1.858.633.0165
P: 1.888.MBS.0165 (1.888.627.0165) (US & Canada)
F: 1.858.633.0166
sales@mybiosource.com
http://www.MyBioSource.com
Profile of MYBIOSOURCE INC.
Return to Antibodies